Table 1.
Patient Characteristic | Implanted Patients (n=30) | Nonimplanted Patients (n=18) | P |
---|---|---|---|
Age, mean (SD), y | 64 (9) | 65 (15) | 0.75 |
Male, n (%) | 26 (87) | 14 (78) | 0.45 |
NYHA class, n (%) | 0.86 | ||
I | 0/30 (0) | 0/18 (0) | |
II | 6/30 (20) | 3/18 (17) | |
III | 22/30 (73) | 15/18 (83) | |
IV | 2/30 (7) | 0/18 (0) | |
6 MWD, mean (SD), m | 307 (87) | 284 (104) | 0.42 |
Medical history, n/N (%) | |||
COPD | 6/28 (21) | 5/17 (29) | 0.72 |
CAD | 25/30 (83) | 10/18 (56) | 0.05 |
CABG | 11/30 (85) | 6/18 (56) | 0.55 |
HF admissions in past 12 mo, mean (SD), n | 1.2 (1.5) | 1.5 (1.7) | 0.57 |
Medications, n (%) | |||
Diuretics | 25/30 (83) | 17/18 (94) | 0.39 |
ACE inhibitor/ARB | 27/30 (90) | 18/18 (100) | 0.28 |
β-Blocker | 29/30 (97) | 17/18 (94) | 1.00 |
Echocardiographic parameters, mean (SD) | |||
LVEDD, cm | 6.7 (0.75) | 6.6 (0.94) | 0.83 |
Mitral annular diameter, cm | 4.2 (0.4) | 3.96 (0.45) | 0.06 |
LVEF, mean (SD), % | 30 (8) | 29 (8) | 0.59 |
6 MWD indicates 6-minute walk distance; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CABG, coronary artery bypass graft; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; LVEDD, left ventricular end-diastolic diameter; and LVEF, left ventricular ejection fraction.